Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Li Zhe

Showing results (11-20 of 147) with videos related to

Pageof 15
Sort By:
Hybridoma (2005)|December 23, 2009
An anti-DLK1 monoclonal antibody produced using ELISA and hybridoma techniquesZhong-hui Jin, Li-zhe Zhao, Yanyan Zhang, et al.
Journal of Clinical Laboratory Analysis|March 18, 2022
MiR-363-3p promotes prostate cancer tumor progression by targeting Dickkopf 3Li-Zhe Xu, Jin-Zhuo Ning, Yuan Ruan, et al.
Journal of Cellular and Molecular Medicine|December 10, 2024
COL10A1 Facilitates Prostate Cancer Progression by Interacting With INHBA to Activate the PI3K/AKT PathwayKun Jiang, Li-Zhe Xu, Fan Cheng, et al.
Heliyon|July 14, 2023
Targeted poverty alleviation initiatives and corporate sustainable value creation: Determining the role of corporate internal governance control in ChinaChai Bin-Feng, Li Zhe, Sultan Sikandar Mirza, et al.
Functional & Integrative Genomics|March 8, 2023
MiR-124-3p inhibits tumor progression in prostate cancer by targeting EZH2Bao-Feng Song, Li-Zhe Xu, Kun Jiang, et al.
European Journal of Pediatrics|January 4, 2014
Diffuse lung metastases in a child with blastic plasmacytoid dendritic cell neoplasm and reviewXiao-dan Zhong, Li-zhe Wang, Xiao Wang, et al.
Cancer Cell International|September 26, 2023
FAP promotes clear cell renal cell carcinoma progression via activating the PI3K/AKT/mTOR signaling pathwayKun Jiang, Li-Zhe Xu, Jin-Zhuo Ning, et al.
Tissue & Cell|August 1, 2022
Oleuropein attenuates testicular ischemia-reperfusion by inhibiting apoptosis and inflammationLi-Zhe Xu, Kai-Xiang He, Jin-Zhuo Ning, et al.
World Journal of Surgical Oncology|August 22, 2023
GREM1 is a potential biomarker for the progression and prognosis of bladder cancerPeng-Cheng Jiang, Li-Zhe Xu, Jin-Zhuo Ning, et al.
Urolithiasis|September 20, 2023
Experience of high polymer gel pad assisted ultrasound monitoring in the treatment of infant urolithiasis during extracorporeal shock wave lithotripsyKang-Jie He, Lu-Lu Jin, Li-Zhe Hu, et al.
Pageof 15

Showing results (11-20 of 147) with videos related to

Sort By:
Pageof 15
Hybridoma (2005)|December 23, 2009
An anti-DLK1 monoclonal antibody produced using ELISA and hybridoma techniquesZhong-hui Jin, Li-zhe Zhao, Yanyan Zhang, et al.
Journal of Clinical Laboratory Analysis|March 18, 2022
MiR-363-3p promotes prostate cancer tumor progression by targeting Dickkopf 3Li-Zhe Xu, Jin-Zhuo Ning, Yuan Ruan, et al.
Journal of Cellular and Molecular Medicine|December 10, 2024
COL10A1 Facilitates Prostate Cancer Progression by Interacting With INHBA to Activate the PI3K/AKT PathwayKun Jiang, Li-Zhe Xu, Fan Cheng, et al.
Heliyon|July 14, 2023
Targeted poverty alleviation initiatives and corporate sustainable value creation: Determining the role of corporate internal governance control in ChinaChai Bin-Feng, Li Zhe, Sultan Sikandar Mirza, et al.
Functional & Integrative Genomics|March 8, 2023
MiR-124-3p inhibits tumor progression in prostate cancer by targeting EZH2Bao-Feng Song, Li-Zhe Xu, Kun Jiang, et al.
European Journal of Pediatrics|January 4, 2014
Diffuse lung metastases in a child with blastic plasmacytoid dendritic cell neoplasm and reviewXiao-dan Zhong, Li-zhe Wang, Xiao Wang, et al.
Cancer Cell International|September 26, 2023
FAP promotes clear cell renal cell carcinoma progression via activating the PI3K/AKT/mTOR signaling pathwayKun Jiang, Li-Zhe Xu, Jin-Zhuo Ning, et al.
Tissue & Cell|August 1, 2022
Oleuropein attenuates testicular ischemia-reperfusion by inhibiting apoptosis and inflammationLi-Zhe Xu, Kai-Xiang He, Jin-Zhuo Ning, et al.
World Journal of Surgical Oncology|August 22, 2023
GREM1 is a potential biomarker for the progression and prognosis of bladder cancerPeng-Cheng Jiang, Li-Zhe Xu, Jin-Zhuo Ning, et al.
Urolithiasis|September 20, 2023
Experience of high polymer gel pad assisted ultrasound monitoring in the treatment of infant urolithiasis during extracorporeal shock wave lithotripsyKang-Jie He, Lu-Lu Jin, Li-Zhe Hu, et al.
Pageof 15